ArticleGenes & diseases2026

Integrative pan-cancer analysis identifies CCHCR1 as a prognostic biomarker and therapeutic target driving EMT in hepatocellular carcinoma via PI3K/AKT activation.

Shuting Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.